Effect of bismuth subsalicylate on ciprofloxacin bioavailability.
AUTOR(ES)
Rambout, L
RESUMO
A single oral dose of 528 mg of bismuth subsalicylate (30 ml of Pepto-Bismol) had no significant effect on the plasma pharmacokinetics of a single oral dose of 750 mg of ciprofloxacin administered to 12 healthy volunteers (six men and six women). These results suggest that ciprofloxacin bioavailability will not be significantly decreased by single doses of bismuth subsalicylate when the two medications are administered simultaneously.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=284708Documentos Relacionados
- Effects of ranitidine and sucralfate on ketoconazole bioavailability.
- Effect of dose size on bioavailability of ciprofloxacin.
- Effect of renal function on the bioavailability of ciprofloxacin.
- Fatal salicylate toxicity from bismuth subsalicylate.
- Effect of staggered dose of calcium on the bioavailability of ciprofloxacin.
